Assam Medical College and Hospital, Dibrugarh, Kollam.
J Assoc Physicians India. 2022 Apr;70(4):11-12.
Cirrhosis of Liver is a frequent consequence of the long clinical course of all chronic liver diseases, and it is characterised by tissue fibrosis and the transformation of normal liver architecture into structurally abnormal nodules. The prothrombin time-international normalized ratio (PT-INR) to Albumin Ratio (PTAR SCORE) created by Haruki et al. can be quickly calculated at the patient's bedside using a simple formula, INR divided by Serum albumin. Material: A total of 93 patients were entered into the hospital based observational study, and all the participants were followed up during hospital stay. Our study aimed to estimate the international normalized ratio and albumin levels in patients of cirrhosis of liver with sepsis and to find out the association between PT-INR to Albumin Ratio (PTAR Score) on the day of admission with patients outcome during hospital stay.
肝硬化是所有慢性肝病长期临床过程中的常见后果,其特征是组织纤维化和正常肝结构转变为结构异常的结节。Haruki 等人创建的凝血酶原时间-国际标准化比值(PT-INR)与白蛋白比值(PTAR SCORE)可以使用简单的公式在患者床边快速计算,即 INR 除以血清白蛋白。
共有 93 名患者进入该基于观察的医院研究,所有参与者在住院期间均接受了随访。我们的研究旨在估计肝硬化伴脓毒症患者的国际标准化比值和白蛋白水平,并找出入院时 PT-INR 与白蛋白比值(PTAR 评分)与住院期间患者预后之间的关系。
住院期间死亡风险与 PTAR 评分之间的关联仍然具有统计学意义。PTAR 评分对预测住院期间死亡率具有良好的区分能力。为了提高其可行性,我们将 PTAR 评分重新分为三个风险水平(低危:<0.55、中危:0.55-1.00、高危:≥1.00);住院死亡率分别为 14.29%(4/28)、23.08%(9/39)和 76.93%(20/26)。
PTAR 评分系统是预测肝硬化伴脓毒症患者预后的一种方便实用的工具。